Increased IL-12 P40 homodimer secretion by spleen cells duringin vivo growth of the BW-19 T cell hybridoma accompanies suppression of natural immunity

Publisher Website
Google Scholar
Abstract
The high capacity of the T cell hybridoma BW‐19 to metastasize to the spleen, despite its high and moderate sensitivity to lysis by macrophages and natural killer (NK) cells, respectively, appears to be linked to its capacity to suppress local resident NK cell and macrophage activity. Such suppression of splenic NK cell and macrophage activity is accompanied by an increased production of the p40 subunit of interleukin‐12 (IL‐12) by spleen cells. Closer examination revealed that most of the p40 subunit is present under the form of the homodimer (p40)2, whereas the heterodimeric form of IL‐12 is present only in small amounts. Since (p40)2 is known to be a strong antagonist of IL‐12‐mediated effects, i.e., NK cell activation and interferon‐γ (IFN‐γ) secretion, the increased production of (p40)2 after BW‐19 cell inoculation may contribute to the suppression of NK cell and macrophage activity. In addition, we found that the high production of (p40)2 in our tumor model was accompanied by a drastic decrease in IL‐2 and IFN‐γ production by spleen cells, further favoring the possibility that (p40)2 plays a role in the suppression of NK cell and macrophage cytotoxicity. Our results show that normal spleen cells can produce (p40)2 in response to cancer cell growth in vivo and are highly suggestive of a role for (p40)2 in the suppression of natural immunity. Int. J. Cancer 77:460–466, 1998.

This publication has 17 references indexed in Scilit: